ProfileGDS5822 / ILMN_1220940
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 9% 21% 36% 6% 11% 5% 0% 21% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 19.79
GSM1276600PDAC Late Ablation Control 215.121
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.936
GSM1276603PDAC Late Ablation 26.46
GSM1276604PDAC Late Ablation 38.811
GSM1303940PDAC Late Ablation_anti-CTLA4 17.15
GSM1303941PDAC Late Ablation_anti-CTLA4 20.10
GSM1303942PDAC Late Ablation_anti-CTLA4 310.821